Mergers and Acquisitions

Davis Polk is regularly involved in the largest and most complex mergers and acquisitions of the day. Clients engage us when the strategic importance, regulatory or tax complexity, or global scope of a transaction calls for our lawyers.

Clients benefit from Davis Polk's long history of innovation and creative problem-solving. We bring sophisticated judgment, commercial awareness and excellent client service to our clients on the full range of strategic and private equity M&A and commercial transactions.

Seamlessly integrated with our transactional capabilities are unparalleled tax, executive compensation and regulatory practices, including in the areas of antitrust and competition, CFIUS, data privacy, anti-corruption and FCPA.

Recognition

  • According to Thomson Reuters, in 2018, Davis Polk ranked:
    • 1st in announced global M&A
    • 1st among U.S. advisers in announced European M&A
    • 1st among U.S. advisers in announced Latin American M&A
  • Law360 – Among the "M&A Practice Groups of the Year" – 2013, 2014, 2015, 2016, 2017 and 2018
  • Chambers USA, Legal 500 and IFLR1000 – 1st tier among law firms in U.S. M&A (2019)
  • "Americas Law Firm of the Year" – IFLR Americas Awards 2018
  • "M&A Team of the Year" – IFLR Europe Awards 2018
  • "Global M&A Deal of the Year" for CVS's $77B acquisition of Aetna - The American Lawyer 2019
  • "M&A Deal of the Year" for Baker Hughes's merger with GE’s Oil and Gas business – IFLR Americas Awards 2018
  • "M&A Deal of the Year" for Advanced Accelerator Applications's acquisition by Novartis – IFLR Europe Awards 2018 
  • "Global M&A Deal of the Year" – for Syngenta's acquisition by ChemChina - The American Lawyer 2017
  • Chambers USA – Clients say: "It is a seamless team effort. They provide great client service and are trusted advisers in all capacities."
  • Legal 500 U.S – "Davis Polk’s supreme financing and capital markets expertise and its strong presence in the key global financial centers make it a leader for complex and cross-border mega deals."

Notable Matters

Davis Polk has long been the firm of choice for many of the world’s leading blue chip companies and financial institutions.

Our recent transactions include:

Aetna. We advised Aetna on its $77 billion acquisition by CVS Health – named 2018 “Global M&A Deal of the Year” by The American Lawyer.

Shire. We advised Shire on its $62 billion acquisition by Takeda Pharmaceutical in the largest cross-border ever in pharmaceutical industry.

Syngenta. We advised Syngenta on its $43 billion acquisition by ChemChina – the largest Chinese outbound M&A transaction ever and named “M&A Deal of the Year” at the 2018 IFLR European Awards.  

Comcast. We advised Comcast on its $40 billion successful contested acquisition of Sky – Will Pearce was named "Dealmaker of the Year" by The American Lawyer for this representation.

Charles Schwab. We advised Charles Schwab on its pending $26 billion acquisition of TD Ameritrade.

Baker Hughes. We advised Baker Hughes on its $25 billion combination with GE’s oil and gas business – named “M&A Deal of the Year” at the 2018 IFLR Americas Awards.

Reckitt Benckiser. We advised Reckitt Benckiser on its $17.9 billion acquisition of Mead Johnson Nutrition.

IHS Markit. We advised Markit on its $13 billion merger of equals with IHS.

General Electric. We advised GE on the $11.1 billion merger of GE Transportation and Wabtec.

Williams. We advised Williams Companies on its $10.5 billion acquisition of all of the outstanding public common units of Williams Partners in an all stock-for-unit transaction.

Natura. We advised Natura, a global cosmetics group in Brazil, on its pending $3.5 billion acquisition of Avon Products.

Tencent. We advised Tencent on its pending investment in 10% of Universal Music Group’s share capital.